European ADHD Study Delivers Positive Results
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Blinklab Limited has announced positive results from its European ADHD study, which supports the expansion of its diagnostic platform beyond autism. The findings will guide the company towards regulatory studies in the US, following a similar path taken for its autism product. This announcement also indicates a collaborative effort with Mental Care Group, completed at no cost to Blinklab, showcasing the effectiveness of its research model.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Blinklab
- Letter to Shareholders & Proxy Form
- Notice of Annual General Meeting & Proxy Form
- Trading Halt
- 2026 Annual Report & Appendix 4E
- Appendix 4G & Corporate Governance Statement
Later from Blinklab
- Investor Webinar - Positive European ADHD Study Results
- Resignation and Appointment of Auditor
- Corporate Presentation Update
- Results of AGM
- Former Apple Health Clinical Lead Appointed to the Board
Follow Blinklab into a list and get an email when it puts out news.
Follow Blinklab